Targeted copy number analysis outperforms histologic grading in predicting patient survival for WHO grades II/III IDH-mutant astrocytomas

Ítems similars

• IDH mutant lower grade (WHO Grades II/III) astrocytomas can be stratified for risk by CDKN2A, CDK4 and PDGFRA copy number alterations
  per: Yang, Rui Ryan, et al.
  Publicat: (2019)
• Establishing a prognostic threshold for total copy number variation within adult IDH-mutant grade II/III astrocytomas
  per: Mirchia, Kanish, et al.
  Publicat: (2019)
• IDH mutant diffuse and anaplastic astrocytomas have similar age at presentation and little difference in survival: a grading problem for WHO
  per: Reuss, David E., et al.
  Publicat: (2015)
• MR Imaging phenotype correlates with extent of genome-wide copy number abundance in IDH mutant astrocytomas
  per: Wu, Chih-Chin, et al.
  Publicat: (2019)
• PATH-42. IDH-MUTANT LOWER-GRADE ASTROCYTOMAS CAN BE STRATIFIED FOR RISK BY CDKN2A, CDK4 AND PDGFRA COPY NUMBER ALTERATIONS
  per: Rui Yang, Ryan, et al.
  Publicat: (2019)